Hepion Pharmaceuticals Inc (HEPA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 19,347 | 48,448 | 45,489 | 30,403 | 20,146 |
| Operating Income | -19,347 | -48,448 | -45,489 | -30,403 | -20,146 |
| Interest Expense | 1,247 | 10 | 10 | 9 | 31 |
| Other Income | 4,432 | -878 | 415 | -2,310 | -146 |
| Pre-tax Income | -16,162 | -49,335 | -45,084 | -32,722 | -20,323 |
| Income Tax | -2,969 | -409 | -2,884 | N/A | 31 |
| Net Income Continuous | -13,192 | -48,926 | -42,200 | -32,722 | -20,354 |
| Net Income | $-13,192 | $-48,926 | $-42,200 | $-32,722 | $-20,354 |
| EPS Basic Total Ops | -107.35 | -616.07 | -595.00 | -470.00 | -2,100.00 |
| EPS Basic Continuous Ops | -107.26 | -619.32 | -553.66 | -465.52 | -2,103.11 |
| EPS Diluted Total Ops | -107.35 | -616.07 | -595.00 | -470.00 | -2,100.00 |
| EPS Diluted Continuous Ops | -107.26 | -619.32 | -553.66 | -465.52 | -2,103.11 |
| EPS Diluted Before Non-Recurring Items | -107.35 | -616.00 | N/A | -470.00 | -2,100.00 |
| EBITDA(a) | $-18,047 | $-45,191 | $-43,540 | $-30,317 | $-20,112 |